Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class ITerminatedApr 24, 2024Atovaquone Oral Suspension USPMicrobial contamination of a non-sterile product: potential Bacillus cereus contamination.AvKARE · D-0444-2024Class IIITerminatedApr 24, 2024Digoxin TabletsFailed Impurities/Degradation SpecificationsNovitium Pharma LLC · D-0443-2024Class ITerminatedApr 24, 2024Vancomycin Hydrochloride for Oral SolutionSuperpotent Drug: Due to overfilling of drug powderAmneal Pharmaceuticals of New York, LLC · D-0442-2024Class IIICompletedApr 24, 2024NEXLIZETFailed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.Esperion · D-0441-2024Class IOngoingApr 17, 2024Methocarbamol InjectionPresence of Particulate MatterEugia US LLC · D-0440-2024Class IIOngoingApr 17, 2024Isotretinoin CapsulesSuperpotent Drug: The 3-month stability result for assay was found to be above specification limitTeva Pharmaceuticals USA, Inc · D-0439-2024Class IITerminatedApr 17, 2024Lansoprazole Delayed-Release Capsules USPCGMP DeviationsNATCO Pharma Limited · D-0438-2024Class IITerminatedApr 17, 2024Rifampin Capsules USPSubpotent DrugLupin Pharmaceuticals Inc. · D-0437-2024Class IIOngoingApr 10, 2024FentaNYL citrateLack of Assurance of Sterility: Firm did not perform process validation.SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0436-2024Class IIOngoingApr 10, 2024Phenylephrine HClLack of Assurance of Sterility: Firm did not perform process validation.SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0435-2024Class IIITerminatedApr 10, 2024Cyclophosphamide for InjectionLabeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of...X-Gen Pharmaceuticals Inc. · D-0434-2024Class IIITerminatedApr 10, 2024Cyclophosphamide for InjectionLabeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of...X-Gen Pharmaceuticals Inc. · D-0433-2024Class IIOngoingApr 10, 2024fentaNYL Citrate 2Lack of Assurance of Sterility: leaking bagsIntegraDose Compounding Services LLC · D-0432-2024Class IITerminatedApr 10, 2024Lactated Ringer's Injection USPLack of assurance of sterility: bags have the potential to leak..B. Braun Medical Inc · D-0431-2024Class IIOngoingApr 10, 2024Diltiazem Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability study.Glenmark Pharmaceuticals Inc., USA · D-0430-2024Class IOngoingApr 3, 2024Treprostinil InjectionPresence of Particulate Matter.Par Sterile Products LLC · D-0429-2024Class IITerminatedApr 3, 2024Tri-Lo-SprintecFailed Dissolution SpecificationsTeva Pharmaceuticals USA, Inc · D-0428-2024Class IITerminatedApr 3, 2024VCF Vaginal Contraceptive FilmcGMP DiviationsApothecus Pharmaceutical Corp. · D-0427-2024Class IITerminatedApr 3, 2024Divalproex Sodium Extended-release TabletsFailed dissolution specificationsAmneal Pharmaceuticals of New York, LLC · D-0426-2024Class IITerminatedApr 3, 2024VANCOMYCIN 1.25 g added to 0.9% Sodium Chloride 250 mL InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0425-2024Class IITerminatedApr 3, 2024SUCcinylcholine Chloride 100 mg/5mL InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0424-2024Class IITerminatedApr 3, 2024SUCcinylcholine Chloride 200 mg/10mL InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0423-2024Class IITerminatedApr 3, 2024Sodium Citrate 4% 3 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0422-2024Class IITerminatedApr 3, 2024PHENYLephrine HCl 800 mcg/10 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0421-2024Class IITerminatedApr 3, 2024PHENYLephrine HCl 800 mcg/10 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0420-2024Class IITerminatedApr 3, 2024PHENYLephrine HCl 40 mg in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0419-2024Class IITerminatedApr 3, 2024PHENYLephrine HCl 400 mcg/10 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0418-2024Class IITerminatedApr 3, 2024PHENYLephrine HCl 5000 mcg/50 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0417-2024Class IITerminatedApr 3, 2024PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0416-2024Class IITerminatedApr 3, 2024PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0415-2024Class IITerminatedApr 3, 2024PHENYLephrine HCl 1000 mcg/10 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0414-2024Class IITerminatedApr 3, 2024neostigmine methylsulfate 5 mg/5 mL InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0413-2024Class IITerminatedApr 3, 2024Midazolam HCl 100 mg/100 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0412-2024Class IITerminatedApr 3, 2024labetalol HCl 20 mg/4mL InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0411-2024Class IITerminatedApr 3, 2024HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0410-2024Class IITerminatedApr 3, 2024HYDROmorphone HCl 30 mg/30mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0409-2024Class IITerminatedApr 3, 2024HYDROmorphone HCl 25 mg/25 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0408-2024Class IITerminatedApr 3, 2024HYDROmorphone HCl 10 mg/50 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0407-2024Class IITerminatedApr 3, 2024HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium ChlorideLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0406-2024Class IITerminatedApr 3, 2024HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0405-2024